Laparoscopic Versus Open Radical Hysterectomy in Early-Stage Cervical Cancer
LAP-OPEN
Radical Laparoscopic-assisted Hysterectomy Versus Open Radical Hysterectomy in Early-Stage Cervical Cancer: A Comparative Study
1 other identifier
interventional
60
1 country
1
Brief Summary
The study aims to compare laparoscopic-assisted radical hysterectomy with open radical hysterectomy in women with early-stage cervical cancer. A total of 60 patients diagnosed with FIGO stage IA1, IA2, and IB1 cervical cancer were enrolled and randomly assigned into two equal groups: laparoscopic surgery and open surgery. All patients underwent total hysterectomy, bilateral adnexectomy, and pelvic lymph node dissection. Perioperative outcomes were evaluated, including operative time, blood loss, complications, and hospital stay, as well as long-term oncological outcomes such as recurrence, recurrence-free survival, and overall survival. Patients were followed for up to three years postoperatively. The findings of this study aim to assess the safety, feasibility, and clinical effectiveness of laparoscopic-assisted surgery compared with the conventional open approach in the management of early-stage cervical cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2024
CompletedFirst Submitted
Initial submission to the registry
March 27, 2026
CompletedFirst Posted
Study publicly available on registry
June 4, 2026
CompletedJune 4, 2026
March 1, 2026
2.9 years
March 27, 2026
May 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Operative Time
The surgery duration will be measured in minutes from skin incision to closure.
Intraoperative period (day of surgery)
Intraoperative Blood Loss volume
Assessment of volume of intraoperative blood loss (mL): Estimated blood loss volume measured in millilitres during surgery.
Intraoperative period
Length of Hospital Stay
Duration of hospital stay measured in days from surgery to discharge
Up to 30 days post-surgery
Secondary Outcomes (1)
Recurrence Rate
Up to 3 years postoperatively
Study Arms (2)
Laparoscopic Radical Hysterectomy
EXPERIMENTALIn this study, participants underwent radical hysterectomy with bilateral adnexectomy and lymph node dissection using a laparoscopic approach, and vaginal stump closure using an endoscopic stapler was performed.
Open Radical Hysterectomy
ACTIVE COMPARATORUnder conventional surgical techniques in this group , participants underwent open abdominal radical hysterectomy with bilateral adnexectomy and dissection of pelvic lymph nodes.
Interventions
In this procedure, a minimally invasive laparoscopic-assisted radical hysterectomy is performed, including dissection of the pelvic lymph nodes and closure of the vaginal stump with an endoscopic stapler.
A standard open abdominal radical hysterectomy includes dissection of the pelvic lymph nodes and the closure of the vaginal stump.
Eligibility Criteria
You may qualify if:
- FIGO stage IA1, IA2, IB1
- patients with a tumor size \< 2 cm by MRI or pathological assessment after conization
- tumours with histopathological subtypes: squamous cell carcinoma, adenocarcinoma and adeno-squamous carcinoma (
- patients with adequate; hematopoietic, renal and liver functions:
- patients with BMI \< 35 (
- patients with age range 38 - 65 years old.
You may not qualify if:
- patients with mental, heart, bladder, liver, or kidney illness
- patients who had received pre-operative chemotherapy or radiotherapy pregnant patients
- patients with incomplete data or lost follow-up
- patients with radiological evidence of invasion of the outer 1/3 of the cervical stroma or the lower uterine segment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zagazig University Hospitals
Zagazig, Sharqia Province, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ola A Harb, Professor
Zagazig University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- This study is an open-label study due to the nature of the surgical interventions, where neither participants nor investigators were blinded
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2026
First Posted
June 4, 2026
Study Start
March 1, 2021
Primary Completion
January 31, 2024
Study Completion
January 31, 2024
Last Updated
June 4, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Data contains patient information